Zura Bio Ltd Ordinary Shares - Class A ZURA 深 沪
已收盘 08-01 16:00:00 美东时间
1.50
+0.100
+7.14%
华盛通- 最 高1.515
- 今 开1.37
- 成交量 47.11万股
- 最 低 1.345
- 昨 收 1.40
- 总市值 9281.25万
- 52周最高 5.07
- 市盈率 静 --
- 换手率 0.76%
- 52周最低 0.97
- 委 比 -80.79%
- 总股本 6187.50万
- 历史最高 37.55
- 量 比 1.41
- 振 幅 12.14%
- 历史最低 0.97
- 每 手 1
- 风险率 1.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | 美国本土无人机、石墨概念股集体大涨！PDYN升逾31%、QS涨近20%
美商务部启动无人机、石墨行业进口限制！美国本土无人机商PDYN大涨逾31%，石墨电极公司QS大涨近20%>>
07-18 19:03
Zura Bio appoints Eric Hyllengren as CFO
Zura Bio (NASDAQ:ZURA) has announced the appointment of Eric Hyllengren as CFO, effective July 7, 2025. He will succeed Verender Badial, who will step down from the role and remain with the company as...
07-01 19:44
H.C. Wainwright Remains a Hold on Zura Bio (ZURA)
H.C. Wainwright analyst Mitchell Kapoor reiterated a Hold rating on Zura Bio (Z...
05-19 20:16
美股大行评级 | 潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
05-10 10:00
Oppenheimer Maintains Outperform on Zura Bio, Lowers Price Target to $17
Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $19 to $17.
05-10 01:50
美股大行评级 | 潜在涨幅117.92%！Proficient Auto Logistics获Stifel升目标价至18美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1114836103639961600.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Stifel：维持Proficient Auto Logistics(PAL)"买入"评级，目标价从17美元升至18美元</p> <p>• Craig-Hallum：上调Sportsman's Warehouse(SPWH
04-04 15:42
美股大行评级 | 潜在涨幅345.1%！Corvus Pharma获Oppenheimer升目标价至15美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1112300378952404993.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Corvus Pharma(CRVS)"跑赢大市"评级，目标价从14美元升至15美元</p> <p>• 富国银行：上调Regulus Therapeutics(RGLS)评级至"超配"，目标价从
03-28 09:06
Zura Bio reports FY results
Zura Bio press release (NASDAQ:ZURA): FY net loss of $52,403. Cash runway anticipated through 2027, supporting operations and funding anticipated tibulizumab data readouts in SSc and hidradenitis supp...
03-27 21:14
美股大行评级 | 潜在涨幅706.45%！Guggenheim上调InflaRx目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1111936502896275457.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持InflaRx(IFRX)"买入"评级，目标价从7美元升至10美元</p> <p>• Oppenheimer：维持Corvus Pharma(CRVS)"跑赢大市"评级，目标价从14美元升至15美
03-27 09:48
Zura Bio Limited: 2024 Financial Results and Strategic Progress
Zura Bio Limited ( ($ZURA) ) has released its Q4 earnings. Here is a breakdown ...
03-26 12:00
